ホモジゴス家族性高コレステロール血症の疑いのある症例
Dimitri Speron1, Daniel E Soffer2, Neil J Stone1
1Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States (Speron and Stone).
Journal of clinical lipidology
|February 19, 2026
まとめ
ホモジゴス家族性高コレステロール血症の若い成人では,脂質パネルが正常であり,遺伝子検査の必要性を強調しました. 遺伝子型分析は診断を再分類し,正確な患者ケアのためのチームアプローチを強調しました.
科学分野:
- 心臓病学 心臓病学
- 遺伝学 遺伝学とは
- メタボリック障害 メタボリック障害
背景:
- 家族性高コレステロール血症 (FH) は,高コレステロールを引き起こす遺伝疾患です.
- ホモジゴス型FHは重症で,しばしば早期に心血管疾患を発症します.
- 標準的な脂質パネルは,必ずしも基礎となる遺伝的状態を反映しているとは限りません.
研究 の 目的:
- 正常な脂質パネルにより誤診されたホモジゴス型FHの症例を報告する.
- 正確なFH診断における遺伝子検査の役割を強調する.
- 複雑な遺伝性脂質疾患の管理における多学科アプローチの重要性を強調する.
主な方法:
- 若い成人患者の症例報告.
- 臨床プレゼンテーションと脂質プロフィールのレビュー.
- 遺伝子型を決定するための詳細な遺伝子分析.
- フェノタイプ-ゲノタイプ相関.
主要な成果:
- この患者は当初,ホモジゴス型FHと診断されていたが,正常な脂質パネルを呈した.
- 遺伝的再評価により,診断が修正されました.
- 臨床的フェノタイプと初期遺伝的発見の間の不一致が観察されました.
結論:
- 遺伝子検査はFHの診断に不可欠であり,特に脂質プロファイルが不一致した症例では特に重要です.
- 遺伝学者や臨床医を含むチームベースのアプローチは,FHの正確な診断と最適な治療のために不可欠です.
- ホモジゴス型FHの早期かつ正確な診断は,早発の心血管疾患を予防するために不可欠です.
関連する概念動画
Cardiomyopathy III: Hypertrophic Cardiomyopathy
545
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
545
Cholesterol: Significance and Regulation
1.6K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.6K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
592
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
592
Pharmacogenomics: Identification of New Drug Targets
27
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
27
Atherosclerosis III: Management
465
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465
Genetic Lingo
115.8K
Overview
115.8K


